title: Effects of dopamine on L-type Ca2+ current in single atrial and ventricular myocytes of the rat.
abstract: 1. The effects of dopamine on the L-type Ca2+ current (ICa,L) of both atrial and ventricular single myocytes and on the force of contraction of atrial trabeculae in rat heart were investigated. 2. Dopamine increased atrial ICa,L at concentrations higher than 1 microM, but had little or no effect on ICa,L at lower concentrations. The increase in ICa,L at high concentrations was reversed by propranolol and acetylcholine, but not by phentolamine. Activation and inactivation kinetics of ICa,L were not altered by dopamine. 3. In rat ventricular myocytes in which the D4 receptor mRNA does not express, dopamine (20-100 microM) also increased the ICa,L amplitude and propranolol reversed this effect. 4. Clozapine, a potent D4 receptor antagonist, blocked the augmenting effect of dopamine on ICa,L. However, this effect could be explained by beta-antagonism, since clozapine also inhibited the isoprenaline effect. 5. In the atrial trabeculae, the increase in contraction by dopamine (1 to 30 microM) was reversed by 1 microM propranolol, but not by 2 microM phentolamine. Low doses of dopamine (0.01 to 0.3 microM) did not affect the contraction in the controls or during a modest stimulation of the beta-adrenoceptor with 0.01 microM isoprenaline. 6. These results indicate that the positive inotropic action of dopamine is mediated through direct stimulation of the beta-adrenoceptor in both atrial and ventricular myocytes. Involvement of D4 receptor appears unlikely in the regulation of the atrial contraction.
authors.affiliation: Department of Anatomy and K.K. Leung Brain Research Centre, The 4th Military Medical University, Xian, People's Republic of China.
authors.forename: H
authors.initials: H
authors.lastname: Zhao
authors.forename: S
authors.initials: S
authors.lastname: Matsuoka
authors.forename: Y
authors.initials: Y
authors.lastname: Fujioka
authors.forename: A
authors.initials: A
authors.lastname: Noma
mesh_terms: D000818:Animals; D015220:Calcium Channels / Q000187:drug effects*; D020746:Calcium Channels, L-Type; D003024:Clozapine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D009200:Myocardial Contraction / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D050638:Receptors, Dopamine D4
chemical_list: D015220:Calcium Channels; D020746:Calcium Channels, L-Type; C493601:Drd4 protein, rat; D011943:Receptors, Adrenergic, beta; D017448:Receptors, Dopamine D2; D050638:Receptors, Dopamine D4; D003024:Clozapine; D004298:Dopamine